Pfizer (PFE)
(Real Time Quote from BATS)
$28.06 USD
+0.36 (1.30%)
Updated Jul 5, 2024 03:55 PM ET
After-Market: $28.05 -0.01 (-0.04%) 4:12 PM ET
3-Hold of 5 3
B Value F Growth D Momentum D VGM
Price, Consensus and EPS Surprise
PFE 28.06 +0.36(1.30%)
Will PFE be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for PFE based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for PFE
Pfizer (PFE) Stock Falls in a Year: Time to Buy, Sell or Hold?
CHMP Endorses Moderna's (MRNA) mRNA-based RSV Vaccine
PFE: What are Zacks experts saying now?
Zacks Private Portfolio Services
CDC Narrows Age Recommendation for Use of RSV Vaccine
Pfizer (PFE), BioNTech's Updated COVID-19 Jab Gets CHMP Nod
Moderna (MRNA) Shares Decline on RSV Vaccine Efficacy Data
Other News for PFE
This Is What Whales Are Betting On Pfizer
High Dividend 50: Pfizer Inc.
Dividend Roundup: Kroger, AT&T, Pfizer, JPMorgan, and more
The Top 3 Weight Loss Drug Stocks to Buy for Huge Gains
IN BRIEF: Pfizer and BioNTech receive European regulatory recommendation for Covid vaccine